Mark D. Hornstein

No ORCID on file · 67 papers in corpus
2002
·doi:10.1016/s0015-0282(01)03168-5
rct 2002
·doi:10.1097/00006250-200205000-00008

In Brief OBJECTIVE To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three “add-back” regimens. METHODS This is a post-treatment follow-up analysis of a randomized, double-m…

rct 2002
Obstetrics and gynecology ·doi:10.1016/s0029-7844(02)01945-2

OBJECTIVE: To assess post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three "add-back" regimens. METHODS: This is a post-treatment follow-up analysis of a randomized, double-masked,…

nonrandomized-trial 1998
Fertility and sterility ·doi:10.1016/s0015-0282(98)00153-8

OBJECTIVE: To compare basal gonadotropin and estradiol levels between women using acetaminophen versus those using no or other types of analgesics. DESIGN: Observational study. SETTING: Three IVF clinics in greater Boston. PATIENT(S): Th…

observational 1998
Journal of assisted reproduction and genetics ·doi:10.1023/a:1023048318719

PURPOSE: The effect of endometriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization (IVF) cycles was evaluated. METHODS: Forty-five women had "chocolate" cysts aspirated at the time of oocyte retrieval, an…

1998
·doi:10.1097/00006250-199805000-00030

Hornstein, Mark D. MD; Surrey, Eric S. MD; Weisberg, Gerald W. MD; Casino, Leigh A. MT Author Information

rct 1998
Obstetrics and gynecology ·doi:10.1016/s0029-7844(97)00620-0

OBJECTIVE: To evaluate the efficacy and safety of a GnRH agonist, leuprolide acetate depot, alone and in combination with three hormonal add-back regimens in the management of endometriosis-associated pelvic pain. METHODS: Two hundred and …

nonrandomized-trial 1997
Fertility and sterility ·doi:10.1016/s0015-0282(97)81432-x

OBJECTIVE: To assess the efficacy, safety, and effect on bone mineral density of a 3-month course of retreatment with intranasal nafarelin acetate for recurrent symptoms of endometriosis. DESIGN: Multicenter, open-label, nonrandomized clin…

rct 1997
Fertility and sterility ·doi:10.1016/s0015-0282(97)00360-9

OBJECTIVE: To evaluate the efficacy of the GnRH agonist (GnRH-a) nafarelin compared with placebo administered for 6 months after reductive laparoscopic surgery for symptomatic endometriosis. DESIGN: Randomized, prospective, placebo-control…

observational 1996
Molecular human reproduction ·doi:10.1093/molehr/2.3.149

To explore a possible connection between endometriosis, Müllerian anomalies, and possession of the N314D allele of the gene for galactose-1-phosphate uridyl transferase (GALT), we studied 33 women with endometriosis attending a fertility cl…

case-report 1995
International Journal of Gynecology & Obstetrics ·doi:10.1016/0020-7292(94)02253-u
rct 1995
Fertility and sterility ·doi:10.1016/s0015-0282(16)57530-x

OBJECTIVES: To determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy in patients treated for 3 and 6 months with nafarelin for symptoms associated with endometriosis. DESIGN: Dou…

diagnostic-accuracy 1995
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136064

Serum CA 125 concentrations are elevated in some women with endometriosis; however, the low sensitivity and specificity of the assay have made it impractical to use it as a diagnostic test for endometriosis. Recently a second-generation CA …

rct 1994
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(94)90136-8

OBJECTIVE: The study intent was to examine long-term effects on bone mass of 3 or 6 months of nafarelin therapy for endometriosis. STUDY DESIGN: Women with established endometriosis (N = 173) were randomized to receive nafarelin (200 micro…

other 1993
Fertility and sterility ·doi:10.1016/s0015-0282(16)56090-7

OBJECTIVE: To evaluate the safety and efficacy of leuprolide acetate depot (LA, Lupron; TAP Pharmaceuticals, Deerfield, IL) plus daily conjugated equine estrogens (Es, Premarin; Wyeth-Ayerst Laboratories, Philadelphia, PA), and medroxyproge…

other 1993
Fertility and sterility ·doi:10.1016/s0015-0282(16)55921-4

OBJECTIVE: To assess the degree of intraobserver and interobserver variability in endometriosis staging using the revised American Fertility Society (AFS) classification of endometriosis. DESIGN: Videotapes of laparoscopies of 20 patients …

rct 1990
Fertility and sterility ·doi:10.1016/s0015-0282(16)53273-7

The purpose of this randomized double blind prospective trial was to study the efficacy and safety of two doses of oral gestrinone in the treatment of endometriosis. Six patients received gestrinone 1.25 mg twice weekly (group I) and six pa…